Skip to content

Clinical trials

Arterial Occlusive Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arterial Occlusive Diseases Country / region: China Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20131
20161
20172
20194
20202
20212
20223
20231
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status8
Enrolling by invitation2
Recruiting2
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Northland Biotech. Co., Ltd.4
China National Center for Cardiovascular Diseases3
Shenzhen People's Hospital3
Harbin Medical University2
Peking Union Medical College Hospital2
Beijing Luhe Hospital1
Beijing Tiantan Hospital1
Cai gaojun, MD1
Guozhe Sun1
JW Medical Systems Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arterial Occlusive Diseases24
Coronary Artery Disease9
Vascular Diseases6
Arteriosclerosis5
Cardiovascular Diseases5
Chronic Limb-Threatening Ischemia5
Heart Diseases5
Ischemia5
Myocardial Ischemia5
Acute Coronary Syndrome4

Trials

Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.